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Abstract
Differences in ex vivo cell culture conditions can drastically affect stem cell physiology. We sought to establish an assay for
measuring the effects of chemical, environmental, and genetic manipulations on the precision of repair at a single DNA
double-strand break (DSB) in pluripotent and somatic human cells. DSBs in mammalian cells are primarily repaired by either
homologous recombination (HR) or nonhomologous end-joining (NHEJ). For the most part, previous studies of DSB repair in
human cells have utilized nonspecific clastogens like ionizing radiation, which are highly nonphysiologic, or assayed repair
at randomly integrated reporters. Measuring repair after random integration is potentially confounded by locus-specific
effects on the efficiency and precision of repair. We show that the frequency of HR at a single DSB differs up to 20-fold
between otherwise isogenic human embryonic stem cells (hESCs) based on the site of the DSB within the genome. To
overcome locus-specific effects on DSB repair, we used zinc finger nucleases to efficiently target a DSB repair reporter to a
safe-harbor locus in hESCs and a panel of somatic human cell lines. We demonstrate that repair at a targeted DSB is highly
precise in hESCs, compared to either the somatic human cells or murine embryonic stem cells. Differentiation of hESCs
harboring the targeted reporter into astrocytes reduces both the efficiency and precision of repair. Thus, the phenotype of
repair at a single DSB can differ based on either the site of damage within the genome or the stage of cellular
differentiation. Our approach to single DSB analysis has broad utility for defining the effects of genetic and environmental
modifications on repair precision in pluripotent cells and their differentiated progeny.
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Introduction
The preservation of genomic integrity requires the recognition
and repair of a vast array of DNA damage, including strand breaks
and chemical base modifications. DNA double-strand breaks
(DSBs) are particularly challenging to repair, as neither strand
remains intact to template repair for the other. DSB repair in
mammalian cells either utilizes a homologous template or involves
nonhomologous end-joining (NHEJ). The ‘‘classical’’ pathway of
NHEJ, which is essential for lymphocyte antigen receptor
rearrangements and ionizing radiation resistance, is mediated by
the DNA end-binding heterodimer KU70/KU80, the kinase
DNA-PKcs, the XRCC4/XLF/LIG4 ligase complex, and the
endonuclease Artemis [1,2].
DSB repair that utilizes a homologous template can either
involve homologous recombination (HR) or single-strand anneal-
ing (SSA) [3]. In both pathways, the DSB end is processed to a
single-strand 39 tail. In HR, the single-strand tail undergoes
RAD51-dependent invasion of a homologous duplex followed by
template-dependent synthesis. HR is generally considered to be a
precise form of repair, because it can restore the original sequence
if the sister chromatid or another identical sequence is used as a
template [4]. HR can be mutagenic if the template is similar but
not identical to the broken sequence. For example, HR between
homologous chromosomes can result in loss of heterozygosity.
SSA, in contrast with HR, involves the annealing of sequence
repeats located near the DSB. SSA is always mutagenic, as the
sequence between the repeats is deleted. SSA has different genetic
requirements from HR and does not involve strand invasion [5].
The balance between DSB repair pathways is a key determinant
of repair precision, and appears to differ between cell types and
during different phases of the cell cycle [6]. HR is most active
during the late S and G2 phases, when the sister chromatid is
available to template repair. NHEJ predominates in G0 and G1,
when HR could promote loss of heterozygosity, but remains active
throughout the cell cycle [2]. At least to some extent, the pathways
are competitive. For example, loss of classical NHEJ factors
promotes HR at an endonuclease-mediated DSB [7]. Similarly,
loss of NHEJ proteins can restore homologous recombination and
mitomycin C resistance in cells lacking HR factors [8,9,10].
Stem cells, including embryonic stem cells, have been utilized in
studies of DNA repair as they can be propagated in culture and
lack the genetic alterations present in cancer cells [11]. Previous
studies that characterized DSB repair within both human
embryonic stem cells (hESCs) and somatic stem cells have
primarily utilized nonspecific clastogens, such as ionizing radiation
(IR), to examine effects on survival and cell cycle arrest, as well as
the efficiency of repair and the induction of gross chromosomal
rearrangements [12,13,14,15]. This approach has several short-
comings. First, even low doses of nonspecific clastogens will induce
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20514scores of DSBs within each cell. Under normal circumstances, a
stem cell in situ would not experience such extensive simultaneous
damage, so arguments about the implications of damage response
in this context are tenuous. Second, hESCs irradiated with doses
as low as 2 Gy undergo ATM-dependent cell cycle arrest in the G2
phase [14,16], which may favor the repair of DSBs by HR. Third,
exogenous clastogens like radiation or alkylating agents can
produce chemical base alterations that require end modification
prior to ligation. In contrast, DSBs that result from endogenous
processes, such as cleavage by topoisomerase II or replication fork
collapse, lack DNA adducts and other alterations, and may be
either directly ligated or serve as intermediates for HR. Finally,
repair efficiency (i.e., the rapidity of repair at multiple DSBs) and
repair precision (i.e., repair without sequence alteration) are not
necessarily correlated.
Of great importance, differences in ex vivo cell culture conditions
can drastically affect stem cell physiology. These differences
include propagation in the presence or absence of feeder cells [17],
under conditions of hypoxia [18], or with uniquely conditioned
media [19,20,21]. As so many variables could potentially alter
genetic instability ex vivo, we sought to establish an assay for
measuring the effects of chemical, environmental, and genetic
manipulations on the precision of repair at a single DSB. Such an
assay would have widespread utility for optimizing culture
conditions that maintain genetic integrity during cell propagation,
modification and/or differentiation. To this end, we developed an
approach for site-specific targeting of a single DSB in human cells
within the context of a DNA repair reporter. This allows for the
absolute quantification of imprecise repair by HR, NHEJ and
SSA, which can be compared across various culture conditions,
stages of differentiation, genetic backgrounds or genomic loca-
tions. For the first time, we demonstrate that the phenotype of
repair at a single DSB differs across isogenic hESCs based on
either the site of the DSB within the genome or the stage of cellular
differentiation.
Results
DSB repair in hESCs
To assay the phenotype of repair at a single DSB, we utilized
the Direct Repeat (DR)-GFP reporter developed within the Jasin
laboratory [7]. DR-GFP has been widely utilized in a broad range
of mammalian cell lines to estimate the relative frequencies of
NHEJ, HR and SSA after cleavage at a single recognition site
[22]. DR-GFP (Figure 1A) includes a full-length GFP gene
(SceGFP) disrupted by a recognition site for the I-SceI endonucle-
ase, which cleaves a nonpalindromic 18 bp sequence that is not
present in the human or mouse genomes. After I-SceI cleavage,
HR using a downstream repeat (iGFP) to template repair replaces
the I-SceI recognition site with an LweI site and produces a
functional GFP that can be detected by flow cytometry. Repair by
SSA also replaces the I-SceI recognition site with a LweI site but
does not generate a full-length GFP (Figure 1A). Thus, HR using
the iGFP template, SSA or imprecise NHEJ results in ‘‘loss’’ of the
I-SceI recognition site.
HR that results in a functional GFP could utilize the iGFP
template on either the same chromatid that is cleaved by I-SceI or
the sister chromatid. HR could also utilize the SceGFP on the sister
chromatid, if it is not concurrently cleaved by I-SceI. This would
result in reestablishment of the I-SceI site and no genetic evidence
that the HR took place. Thus, GFP-positive frequency is a
surrogate for the frequency of HR, rather than an absolute
measure of the total number of HR events. Similarly, precise
repair by NHEJ of the I-SceI break without sequence modification
can restore the I-SceI recognition site. A restored site leaves no
genetic evidence of the cleavage and repair event, but becomes a
substrate for subsequent cycle(s) of cleavage and repair [23].
To avoid position effects, we made use of targeted gene addition
with zinc finger nucleases (ZFNs). ZFNs are fusions of the Fok1
nuclease domain and a DNA recognition domain composed of
engineered C2H2 zinc-finger motifs [24]. Upon binding of two
fusion proteins in inverse orientation, dimerization of the nuclease
domains results in site-specific cleavage. Repair of the resulting
DSB by synthesis-dependent strand annealing using an introduced
template can result in gene targeting at high efficiency [25,26]. We
utilized a recently described ZFN set that allows for efficient and
specific targeted integration into the p84 (AAVS1/PPP1R12C)
locus to generate a panel of isogenic lines with DR-GFP targeted
to that position [27]. p84 is considered a ‘‘safe-harbor’’ locus for
integrating transgenes, as it is constitutively expressed across a
variety of cell types and biallelic disruption results in no discernible
phenotype [28,29].
To target DR-GFP, we first attempted an NHEJ-based gene
capture strategy. The HPRT-DRGFP reporter [7], which contains
DR-GFP flanked by sequence from the murine Hprt gene was
linearized and co-transfected with ZFNs targeting the p84 locus
[27] in 293T cells. No sequence homology is present between
HPRT-DRGFP and p84, so integration results solely through
NHEJ. Integrants were analyzed by PCR and fluorescence in situ
hybridization (FISH) for targeting (Figure 2). Overall, 7 (3.6%) of
194 integrants had undergone site-specific targeting, including 4 in
the same orientation as p84 coding sequence and 3 in the opposite
orientation (Figure 2). Thus, even in the absence of any sequence
homology, targeting of the 9.6 kb DR-GFP sequence can be
performed through ZFN-directed NHEJ.
To increase the targeting efficiency, we generated the p84-
DRGFP reporter, which contains the DR-GFP transgene flanked
by 0.8 kb arms identical to intron 1 of p84 (Figure 1A) [27].
Previous studies demonstrated efficient targeting of a smaller
cassette to p84 in hESCs utilizing the same flanking arms and
ZFNs [27,30,31]. We co-transfected p84-DRGFP with the p84
ZFN expression vector into a panel of human cell lines, including
the hESC lines H9 and BG01. Integrants were isolated from single
cell-derived colonies by selection in puromycin. hESCs were
maintained on Matrigel-coated plates in the absence of feeder
cells. The presence of a single integrant was determined by
quantitative PCR (data not shown). Targeting was identified by
PCR (Figure 1B) in 60–80% of puromycin-resistant clones across
all cell lines. Single copy integration and p84 locus targeting were
confirmed by FISH (Figure 1C). Expression of pluripotency
markers was confirmed in hESC clones containing p84-DRGFP
by immunofluorescence microscopy (Figure 1D).
hESCs have very low rates of HR using the iGFP template
To estimate the frequency of I-SceI-induced HR, we transduced
I-SceI into cells containing targeted p84-DRGFP. After 96 hours,
we measured the frequency of GFP+ cells by flow cytometry.
Strikingly, the frequency of GFP+ cells was 20–260-fold lower
among hESCs compared to somatic cell lines and murine ESCs
(mESCs) that each contain a single integrated copy of DR-GFP
(Figure 3A, 3B). The extent of fold reduction observed between
hESCs and the other cell types is similar to that seen from the loss
of HR factors like BRCA2 [32]. The frequency of GFP-positive
mESCs after I-SceI expression (Figure 3B) was similar to previous
reports with these cells [7].
Differences in the expression of I-SceI across cell types could
explain the low frequency of GFP+ hESC recombinants.
However, immunoblotting after I-SceI transduction demonstrated
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points after transduction (Figure 3C).
Even with similar I-SceI protein expression, it is possible that
cutting is somehow less efficient in hESCs. To address this, we
used two different sets of qPCR primers (Table 1) to amplify the
sequence overlapping the I-SceI site. With this approach, the
fraction of cells with cleaved I-SceI at a given time point is
equivalent to the percent reduction in qPCR product compared
Figure 1. Targeting of p84-DR-GFP. A. A DSB formed by I-SceI within the SceGFP gene in p84-DR-GFP can either be repaired by nonhomologous
end-joining, homologous recombination or single-strand annealing. HR using the iGFP template establishes a functional GFP. Precise NHEJ or HR
using the SceGFP on the sister chromatid as a template can reestablish the I-SceI site. Arrows indicate primers for confirming targeting to p84. B. PCR
demonstrates targeting at the 59 and 39 borders of p84-DRGFP. C. FISH demonstrates overlap of the p84 locus (green) and DR-GFP (orange) probes
indicating targeting of DRGFP to the p84 locus in hESCs and HCT116 cells. Insets are magnified images of the indicated regions. D.
Immunofluorescence microscopy for pluripotency markers in H9 hESCs, U20S and 293T cells.
doi:10.1371/journal.pone.0020514.g001
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cells with cleavage at the I-SceI site 24 hours after transduction in
hESCs fell in the same range as the somatic human cell lines
(Figure 3D). We assayed cleavage 24 hours after transduction to
ensure that I-SceI was maximally expressed and to minimize the
number of cells that had undergone imprecise repair and thus
could not be cleaved. The percent of cells cleaved at any given
time point is an imperfect measure of cleavage efficiency, as the
efficiency of repair will also affect the likelihood that any given cell
will be cleaved at a single time point. Nonetheless, similar findings
using the qPCR strategies across cell lines suggests that the
difference in frequency of GFP-positive cells between hESCs and
somatic cell lines does not result from a drastic difference in I-SceI
cutting.
Site of integration affects the frequency of HR
The advantage of utilizing a targeted reporter across multiple
cell lines is the avoidance of potential locus-specific effects on DSB
repair. To determine whether genomic location of the single DSB
truly affects repair phenotype, we analyzed four additional H9
hESC clones that integrated a single copy of DR-GFP at other
sites in the genome, as demonstrated by FISH (Figure 3E).
After expression of I-SceI, the frequency of GFP+ cells varied
significantly across lines, with a nearly 20-fold difference between
the highest and lowest frequency clones (p,0.01; Figure 3F). In
contrast, the frequency of GFP+ cells did not significantly differ
after transduction with a GFP-expressing virus (Figure 3F),
suggesting that the effect on frequency of HR is not due to
differences in transduction efficiency across cell lines. Thus, the
   
 
 
 
    
   
 
 
 
 
 
Figure 2. Site-specific targeting without sequence homology. A. DR-GFP can be integrated at the p84 locus in either orientation. B. PCR with
p84-59 and GFP-39 primers demonstrates three 293T clones with site-specific integration. l indicated DNA ladder. C. FISH demonstrates colocalization
of probes against DR-GFP (green) and spanning the p84 locus (orange) in 293T cells. D. Sequences at 59 and 39 borders of integrated DR-GFP. Red
sequence is from the p84 locus and blue sequence is from the DR-GFP construct. Integration with no sequence modification is indicated as ‘unmod’.
doi:10.1371/journal.pone.0020514.g002
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solely on the site of cleavage within the genome.
Imprecise NHEJ is reduced in hESCs
To determine the overall frequency of I-SceI site loss, we
collected cells 4 days after I-SceI transduction and PCR amplified
the region flanking the I-SceI site (Figure 4) [7]. The fraction of
cells that had undergone sequence modification, either by HR,
NHEJ or SSA, was measured by quantifying the fraction of PCR
product that failed to digest with I-SceI (Figure 4A). The overall
fraction of PCR product resistant to I-SceI cleavage (i.e., the
cumulative I-SceI site loss through NHEJ, HR and SSA) averaged
10.99% in H9 hESCs compared with 53–78% in somatic cell lines
(Figure 4C; p,0.01 for hESCs versus HCT116, HeLa, U2OS or
MCF7).
The overall rate of I-SceI site-loss was 5–7-fold less in hESCs
compared with somatic cell lines, while the frequency of HR using
the GFP template (as measured by percent GFP+) was 20–260-fold
less. In other words, the fraction of I-SceI site loss that resulted
from HR was only 1.18% for hESCs (0.13% GFP-positive/
10.99% site loss) compared to 20.28% (13.1%/64.6%) for U2OS
cells (Figure 4D). Thus, HR contributes a very small fraction of the
overall I-SceI site loss in hESCs.
Next, we digested the PCR products obtained from H9 hESCs
and U2OS cells with LweI, which will cleave amplicons that have
repaired by either HR or SSA (Figure 4B). Approximately 38% of
the PCR product from U2OS cells transduced with I-SceI was
cleaved by LweI. In contrast, no LweI-cleaved product was
detectable from hESCs after I-SceI transduction (the lower limit of
detection is approximately 2%), indicating that site loss through
both HR and SSA is infrequent in hESCs under these conditions.
To more precisely quantify the subset of I-SceI site-loss that
resulted from NHEJ, we digested the PCR products with both I-
SceI and LweI (Figure 4B), which cleaves all products except those
repaired by imprecise NHEJ. Approximately 11% of the product
from hESCs after I-SceI transduction was resistant to digestion
with either I-SceI alone or I-SceI+LweI, confirming that
essentially all I-SceI site loss in these cells is through NHEJ
(Figure 4B). Very similar results were obtained from the four
hESC clones with non-targeted integration of the DR-GFP
reporter at different genomic sites (Figure 4E), indicating that
the frequency of imprecise NHEJ is similar across different
genomic locations. In contrast with the hESCs, LweI cleaved
approximately one-third of the I-SceI undigested product from
U2OS cells (Figure 4D; 42.87% I-SceI+LweI undigested versus
64.61% I-SceI undigested).
Figure 3. HR of I-SceI-induced DSBs in p84-DR-GFP. A. Flow cytometry before or 96 hours after transduction with an I-SceI-expressing
lentivirus. Values represent percent of GFP-positive cells. B. Frequency of GFP-positive cells by flow cytometry 96 hours after I-SceI transduction in
human cell lines, mouse embryonic stem cells (mESC) and two hESC lines. Error bars indicate one standard deviation. C. Immunoblotting with anti-HA
antibodies at various time points after I-SceI transduction. D. Two different sets of qPCR primers were used to amplify the region flanking the I-SceI
site using genomic DNA isolated from cells 24 hours after mock transduction or transduction with I-SceI. The reduction in the amount of amplified
product compared to mock transduction represents the fraction cleaved by I-SceI. E. Localization of nontargeted DR-GFP in hESC clones by FISH
using a probe derived from DR-GFP (orange). F. Frequency of GFP-positive cells by flow cytometry among hESC clones with non-targeted DR-GFP
relative to hESC cells with p84 targeted DR-GFP after transduction of GFP or I-SceI. * indicates p,0.01 compared with p84 targeted DR-GFP.
doi:10.1371/journal.pone.0020514.g003
Table 1. PCR and qPCR primers.
Amplicon Primers (Forward then Reverse)
I-SceI or LweI site-loss 59- AGGGCGGGGTTCGGCTTCTGG
59- CCTTCGGGCATGGCGGACTTGA
Reporter copy number for quantitative PCR 59- CGGCGCCGGCAGGAAGGAA
59- CTCTAGAGCCGCCGGTCACACG
Reference amplicon from APE1 on chr.14 for quantitative PCR 59- CGGCACGCGTGGGATGAA
59- GCCTTGGCGCTCTTGTGG
Nested PCR to determine I-SceI
cleavage efficiency
1
st round, PCR 618 cycles 59- AGGGCGGGGTTCGGCTTCTGG
59- CCTTCGGGCATGGCGGACTTGA
2
nd round, quantitative PCR 59- GACGTAAACGGCCACAAGTT
59- AAGTCGTGCTGCTTCATGTG
or
59- GCAACGTGCTGGTTATTGTG
59- TGCCTCGTGGGTCTTCTACT
Reference amplicon from near p84 on chr.19
for PCR of I-SceI cleavage efficiency
1
st round, PCR 618 cycles 59- TTCTGTGCTGGGGTAGAACC
59- CCAAACCCCAGTCCTCTACA
2
nd round, quantitative PCR 59- CTCAAACTGCATGGCTCAAA
59- CCAAACCCCAGTCCTCTACA
Confirming HPRT-DRGFP targeting at p84
without homologous arms
Same orientation as p84 coding 59 junction 59-AGGATCCTCTCTGGCTCCAT
59-CGAGATCTGATGCCCTCTTC
39 junction 59-TGTAGAGGACTGGGGTTTGG
59-CTTGCTTTCTTTGCCTGGAC
Opposite orientation 59 junction 59-CAGCTCAGGTTCTGGGAGAG
59-TGTAGAGGACTGGGGTTTGG
39 junction 59-GCAAACATGCTGTCCTGAAG
59-TTGCTCTCTGCTGTGTTGCT
doi:10.1371/journal.pone.0020514.t001
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(n=40) and hESCs (n=36) (Table S1). There were no significant
differences in sequence modifications observed at the repair junctions
between the U2OS and hESC clones, including the frequency of
insertions (30% vs. 17%), mean insertion length (3.7 bp vs. 2 bp),
length of deletions (5.9 bp vs. 5.1 bp), and use of short stretches of
overlapping microhomology (67.8% vs. 70% among clones lacking
insertions) (Table S1). Thus, although imprecise NHEJ at a single
DSB was significantly less common in hESCs, the phenotype of
imprecise NHEJ was similar between the two cell types.
Figure 4. Repair through NHEJ, HR or SSA. A. Repair through imprecise NHEJ results in ‘‘loss’’ of the I-SceI site while repair through HR or SSA
replaces the I-SceI site with an LweI site. DNA was isolated 96 hours after I-SceI transduction. After PCR amplification with the F and R primers and
digestion with I-SceI, the uncleaved band (725 bp) represents product from cells that have undergone imprecise repair through any of the three
pathways. B. Digestion of the PCR product with LweI generates a cleaved band (546 bp) that represents product from cells that have undergone HR
or SSA. After digestion with both I-SceI and LweI (indicated as ‘‘Both’’), the uncleaved band represents product from cells that have repaired by
imprecise NHEJ. ‘‘GFP+’’ indicates an I-SceI transduced population that was sorted to be 100% GFP-positive, which served as a control for LweI
digestion. C. Comparison of the fractions of uncleaved product after PCR amplification and I-SceI digestion. * indicates p,0.01 compared with H9.
Error bars indicate one standard deviation. D. Comparison of the fractions of uncleaved product after digestion with the indicated enzymes. ‘‘GFP+’’
values are from flow cytometry after I-SceI transduction (Figure 3B). E. PCR product obtained from H9 hESC clones with non-targeted DR-GFP
96 hours after I-SceI transduction was digested with I-SceI, LweI or both (indicated as ‘I+L’). Untransduced cells are included to demonstrate complete
digestion with I-SceI enzyme.
doi:10.1371/journal.pone.0020514.g004
Targeted DSB Repair in Human Stem Cells
PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e20514DNA-PKcs contributes to repair of clastogen-induced
damage in hESCs
Although site loss in hESCs was predominately mediated by
NHEJ, this does not clarify the relative contributions of NHEJ and
HR to overall repair, as precise repair of the I-SceI break by either
NHEJ or by HR using SceGFP on the sister chromatid will
reestablish the I-SceI site. To address this, we treated hESC,
MCF7 and U2OS lines with 2 Gy of ionizing radiation, a dose
which does not result in significant cell death but can promote G2
cell cycle arrest [14,16]. At fixed time points, we measured the
extent of persistent DNA damage using the neutral comet assay,
which quantifies only DSBs (Figure 5A). The extent of damage
induced by IR, as measured 5 minutes after irradiation, was
reduced in hESCs compared with U2OS and MCF7 cells
(Figure 5A). However, the kinetics of repair of IR-induced breaks
were similar in hESCs, MCF7 and U2OS cells (Figure 5A). For
example, by 4 hour after irradiation, the olive tail moment had
decreased 44% in U2OS cells compared with 48–53% in the
hESC lines (Figure 5A).
Banuelos et al. [33] reported that hESCs, in contrast with
mESCs, express high levels of DNA-PKcs. To determine the
contribution of DNA-PKcs to repair after low-dose IR, we treated
cells with the selective DNA-PKcs enzymatic inhibitor NU7026
[34] before and after irradiation. As expected, NU7026 had no
effect on the overall extent of damage induced by IR, as measured
by the olive tail moment 5 minutes after irradiation (Figure 5A).
NU7026 had a slight effect on repair in U2OS and MCF7 cells,
with an increase in olive tail moment of 1.21-fold and 1.16-fold,
respectively, at 4 hours after irradiation (Figure 5A). The effect
was greater in hESCs, with 1.79-fold and 1.69-fold increases in
olive tail moment in H9 and BG01 cells, respectively (Figure 5A).
Similar results as after irradiation were obtained upon treatment of
hESCs, MCF7 and U2OS cells with the topoisomerase II poison
etoposide (Figure 5B), which induces only DSBs. Thus, even under
conditions that can promote G2 arrest, a sizable fraction of
clastogen-induced DSB repair in hESCs appears to involve DNA-
PKcs.
Single DSB repair in terminally differentiated astrocytes
hESCs can be differentiated along committed lineages into
either multipotent progenitors or terminally differentiated proge-
ny. To determine the effects of neural differentiation on DSB
repair, we differentiated H9 hESC clones harboring DR-GFP into
neural stem cells (NSCs) and then into astrocytes (Figure 6A).
Transduction efficiency in hESCs, NSCs and astrocytes was
similar, based on the fraction of GFP-positive cells after infection
with a GFP-expressing lentivirus (Figure 6B). After transduction of
I-SceI, the percents of GFP-positive cells were similar in hESCs
and NSCs (Figure 6B). However, the percent of GFP-positive cells
after I-SceI transduction was reduced 36–69% in astrocytes
compared to hESCs (Figure 6B; p,0.01).
Cell cycle arrest in G0/G1 could explain the low frequency of
GFP-positive cells after I-SceI transduction. Cell cycle analysis
demonstrated that approximately 86% of astrocytes are in G0/
G1, compared with 43–47% of hESCs and NSCs (Figure 6C). As
a result, the reduced rate of GFP positivity is likely to reflect the
known dependence on NHEJ to repair DSBs in G0/G1. To
determine whether this results in a greater frequency of
i m p r e c i s er e p a i r ,w eP C Ra m p l i f i e dt h es e q u e n c ef l a n k i n gt h e
I-SceI site, as above. While the percent of product resistant to I-
SceI cleavage was similar in hESCs (6.1%) and NSCs (12.5%),
68.5% of product from astrocytes was resistant to I-SceI cleavage
(p,0.01 compared with hESC or NSC) (Figure 6D). After
double digestion with I-SceI and LweI (which cleaves all
products except imprecise NHEJ), more than half of the product
from astrocytes was resistant to cleavage, compared with 6.7%
and 10.1% of product from hESCs and NSCs, respectively
(Figure 6D).
To determine whether the preference for imprecise NHEJ
among astrocytes is associated with either an increase or a
decrease in the overall efficiency of repair, we performed the
comet assay after IR, as above. Astrocytes retained more damage
1, 2 and 4 hours after irradiation (Figure 6E). Thus, terminal
Figure 5. DNA-PKcs-dependent and -independent repair after
low-dose IR. A. Neutral comet assay was performed after irradiation
with 2 Gy in the presence of NU7026 (Nu) or vehicle (Veh) and the olive
tail moment was calculated for at least 50 cells for each condition at the
indicated time points. Error bars indicate one standard deviation.
Indicated ratios are between olive tail moments for the same cell line in
the presence of NU7026 or vehicle. * indicates p,0.01 compared with
same cell line and time point treated with vehicle. B. Comet assays were
performed after treatment with etoposide or vehicle (-).
doi:10.1371/journal.pone.0020514.g005
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capacity, with a preference for NHEJ.
Discussion
We established a targeted reporter system for analyzing the
effects of exogenous manipulations, in vitro differentiation, or
genetic background on the repair of a single DSB in hESCs.
Although other strategies have been used to target specific sites in
pluripotent cells [19,29,35], p84 ZFNs offer the desirable
combination of very high targeting efficiency with a large
(approximately 10 kb) construct and integration at a ‘‘safe’’
harbor locus [27]. Targeting DR-GFP to the same locus across
multiple cell lines avoids potentially confounding locus-specific
differences in repair. In fact, we observed a 20-fold difference in
the frequency of HR based on site of integration. Considering
these findings, targeting of DNA damage to the same site should
be considered the ‘‘standard’’ for future studies that analyze repair
across different genetic backgrounds and cell types.
Under the conditions we utilized, both hESCs and NSCs
repaired a single DSB more precisely than either somatic cell lines
or differentiated astrocytes. Of note, the 10.99% frequency of
imprecise repair at an I-SceI DSB in hESCs is almost certainly an
overestimation of the true frequency after a single break. Precise
repair of an endonuclease-induced DSB, either by NHEJ or
through HR using SceGFP on the sister chromatid, reestablishes
the target site for the endonuclease. A reestablished site is a
substrate for further iterations of cleavage and repair, so the
frequencies of imprecise repair observed in studies like ours may
capture multiple cleavage events within each transduced cell.
Differentiation of hESCs into astrocytes resulted in reductions in
both the efficiency of IR-induced DSB repair and the precision of
I-SceI-induced DSB repair. Adams et al. [36] analyzed the
resolution of IR-induced cH2AX and RAD51 foci in H9 and
BG01V hESCs, as well as differentiated NSCs and astrocytes. In
contrast with our results, they reported a small but statistically
significant increase in the number of cH2AX foci in hESCs,
compared with astrocytes at various time points over the 20 hours
after irradiation [36]. One possible explanation for the discrep-
ancy is that focus resolution is an indirect marker of the kinetics of
DSB repair. We utilized the comet assay to measure DNA repair,
as assessment of the comet tail is a direct measure of DNA
fragmentation. Consistent with our findings that HR is downreg-
ulated in astrocytes, Adams et al. reported that astrocytes have
markedly lower levels of RAD51 protein and do not form RAD51
foci in response to IR [36].
The same group recently utilized a randomly integrated
reporter to quantify NHEJ between two closely-spaced I-SceI
DSBs in a single BG01V cell line [37]. Similar to our findings, the
precision of NHEJ was reduced by differentiation of hESCs into
astrocytes. In the BG01V cells cleaved by I-SceI, NHEJ was
dependent on the Ligase IV co-factor XRCC4 but, in contrast
with our results using IR or etoposide, only slightly affected by
chemical inhibition or RNAi knockdown of DNA-PKcs [37]. One
possible explanation is that DNA-PKcs plays a larger role in the
repair of damage induced by IR or etoposide, compared with
repair between I-SceI breaks. An alternative possibility is that
inhibition of DNA-PKcs suppresses synapsis between DSB ends
[38,39]. Failure to synapse would allow DSB ends to repair with
ends from other breaks, which is required in the two I-SceI break
system utilized by Adams et al. [37].
Neural stem cells had similar repair efficiency and precision to
hESCs propagated under similar conditions. Although both
pluripotent and somatic stem cells proliferate when cultured in
vitro, the latter are primarily quiescent in vivo. Milyavsky et al.
recently reported that human hematopoietic stem cells readily
undergo apoptosis when exposed to ionizing radiation, suggesting
that these cells lack extensive capacity for DSB repair [15].
However, DSBs presumably form very infrequently in somatic
stem cells in vivo, both because quiescent cells are not undergoing
DNA replication and because of their relative metabolic inactivity.
Thus, the ability of a somatic stem cell to orchestrate precise
repair, rather than its efficiency at repairing multiple breaks, is
likely to be the primary determinant of genomic integrity in vivo.
Within a multi-cellular organism, the necessity for faithful repair
in any particular cell may differ across both cell lineage and stage
of differentiation. A common hypothesis is that somatic stem cells
must possess an extensive capacity for precise DNA repair
[40,41,42], based on three arguments. First, somatic stem cells
have long life-spans, during which they could accumulate
potentially deleterious mutations. Second, many somatic stem
cells undergo limited replenishment, suggesting that loss of stem
cell function and/or viability would compromise organ function.
Finally, somatic stem cells are the presumed cell-of-origin for
many types of cancer, so the accumulation of mutations within
these cells would be particularly dangerous to the entire organism.
Similar logic would suggest that pluripotent stem cells, including
hESCs, must also have highly efficient and precise mechanisms for
repairing DNA damage. Mutations acquired within a pluripotent
cell at the zygote or early blastocyst stage of development would
necessarily be inherited within all or a fraction of the organism and
potentially transmitted through the germline. Thus, faithful
preservation of the genome in hESCs could be a highly evolved
necessity.
The contrary argument is that the elimination of stem cells that
incur DNA damage, rather than repair, offers a greater advantage.
The hESC phenotype is presumably quite transient in vivo
compared with overall lifespan, so evolutionary pressure for
uniquely precise DNA repair within these cells seems unlikely.
Instead, the high maternal ‘‘cost’’ of gestation and parturition
could have selected for a low threshold for hESC elimination in
the presence of DNA damage, especially highly mutagenic damage
like DSBs.
In conclusion, we have established a targeted reporter system for
analyzing the effects of environmental, genetic and other
manipulations on the repair of a single DSB in pluripotent and
somatic stem cells, as well as their differentiated progeny. While
hESCs cultured in the absence of feeder cells orchestrate more
precise DSB repair than a panel of somatic cell lines, it will be
important to determine whether changes in culture conditions can
further improve the precision of repair in these and other
Figure 6. Repair at an I-SceI DSB in neural lineage cells. A. Light and immunofluorescence microscopy after differentiation of hESCs. DAPI
indicates cellular nuclei. Neural stem cells are positive for SOX1, PAX6 and Nestin, while astrocytes are positive for GFAP. B. Percent GFP+ cells after
GFP or I-SceI transduction relative to hESCs in two clones differentiated into NSCs and astrocytes. "GFP/ISceI" indicates the ratio of relative values. *
indicates p,0.01 compared to hESCs from the same clone. Error bars indicated one standard deviation. C. Cell cycle distribution in two hESC clones
and their differentiated NSCs and astrocytes. D. PCR amplification of the sequence flanking the I-SceI site from cells 96 hours after I-SceI transduction.
PCR product was digested with I-SceI, LweI or both. "GFP+ sorted" cells were utilized as a control to demonstrate complete LweI cleavage. E. Comet
assay at select time points after irradiation with 2 Gy. Examples are shown of cells quantified by comet assay either prior to or one hour after 2 Gy.
doi:10.1371/journal.pone.0020514.g006
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culture will reduce the likelihood that deleterious mutations, which
could result in either diminished function or malignant transfor-
mation, develop within cellular therapy products. Conversely,
strategies that depend on site-specific genomic editing could be
enhanced by utilizing conditions that promote imprecise repair
[43,44].
Materials and Methods
hESC Culture and Neural Differentiation
The hESC lines H9 and BG01 were purchased from the
National Stem Cell Bank (http://www.wicell.org) at passages 31
and 18, respectively. The cells were cultured on Matrigel (BD
Bioscience) coated plates in mTeSR1 medium (Stem Cell
Technology).
Neural differentiation was performed as described [45,46].
Briefly, hESCs were treated with 1 mg/ml dispase (Stem Cell
Technology) and split to poly-L-lysine/laminin (Sigma) coated
dishes in N2B27 medium (1:1 mix of D-MEM/F12 medium with
1x N2 supplement and Neurobasal medium with 1x B27
supplement (Invitrogen) supplemented with 100 ng/ml mouse
recombinant Noggin (R&D Systems). The cells were split 1:2 every
3–5 days. At approximately the 15
th day (passage 4) when cells
appeared as small rosettes, a portion of the cells was collected and
confirmed to express NSC markers. The remaining cells were
continuously cultured in N2B27 medium with Noggin for 5
additional days and then split using TrypLE (Invitrogen) and
changed to new N2B27 containing 20 ng/ml bFGF (Invitrogen)
and 20 ng/ml EGF (R&D Systems). The cells were maintained in
this condition for approximately 60 days (passage 14) with 1:2 split
every 5–7 days. The bFGF and EGF were withdrawn and the cells
were cultured in N2B27 medium alone. After 7–10 days, cells were
collected and assayed for astrocyte markers.
Non-stem cell culture
293T, MCF7, U2OS, HCT116 and HeLa cells were obtained
from ATCC. HEK293, MCF7 and U2OS cells containing
untargeted DR-GFP and mESCs containing HPRT-targeted
DR-GFP were provided by Maria Jasin (Sloan-Kettering Institute)
and were previously described [7,47,48]. The human cell lines
were cultured in DMEM supplemented with 10% fetal bovine
serum, 0.1 mg/ml penicillin and 0.1 mg/ml streptomycin. The
mESCs were cultured as previously described [7].
Neutral comet assay
Double-strand DNA breaks were measured by neutral microgel
electrophoresis using the CometAssay kit (Trevigen), following the
manufacturer’s instructions with some modifications. To prevent
cleavage at heat- and/or alkali-labile related DNA strand breaks,
all procedures were performed at pH 7.4 and #37uC. Briefly,
exponentially growing cells were treated with IR, etoposide or
mock and then incubated for various times at 37uC to allow for
repair. After incubation, cells were cooled immediately to 4uC,
and a 50 mL aliquot of cells (1610
5 cells/mL) was added to
500 mL of 0.5% low-melting agarose that had been boiled and
then cooled at 37uC for 20 min. After mixing the sample, a 50-mL
aliquot was pipetted onto an area of the CometSlide. The slide was
incubated at 4uC for 10 min to accelerate gelling of the agarose
disc, and then transferred to pre-chilled lysis solution for 30 min at
4uC. After lysis, the cells were first treated with ribonuclease A for
2 h, then with proteinase K for 48 h, both at 20uC. Following
enzyme digestions, slides were subjected to electrophoresis under
neutral conditions (100 mM Tris, 300 mM sodium acetate, pH
adjusted to 8.5 with acetic acid) in a horizontal chamber at 1 V/
cm) for 10 min at room temperature. The slide was fixed in ice-
cold, 100% methanol for 5 min and then immersed in 100%
ethanol at 20uC for 5 min and air dried. For observation, samples
were stained with SYBR-Green (Molecular Probes) and diluted
1:10,000 in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA. Images of
comets were visualized with a Zeiss Axio Observer.A1 after sample
blinding. For DNA damage analysis, we used CometScore 1.5
software (TriTek Corporation) to compute the olive tail moment
(OTM) for 50–100 cells from each sample. Each experiment
(triplicate samples per group) was repeated at least three times.
Cell cycle profile analysis
Cell cycle profiles were based on cell DNA content measured
via flow cytometric analysis. Cells were rinsed with PBS three
times, harvested after treatment with TrypLE (Invitrogen) and
pelleted for 5 min at 1,250 rpm. The cells were resuspended in
PBS, recentrifuged, fixed in 70% (vol/vol) ice-cold ethanol, and
incubated on ice for at least 30 min. Immediately before analysis,
the cells were pelleted by centrifugation for 5 min at 1,250 rpm
and resuspended at 10
6 cells/ml in PBS containing 50 mg/ml
propidium iodide and 100 mg/ml RNase A (both from Sigma).
The histograms of cell number versus DNA content were
generated by flow cytometric analysis on a FACSCanto II (BD
BioSciences). The data were analyzed using Modfit LT software
(Verity Software House).
Western blot analysis
Cells (10
6–10
7) were harvested and resuspended in 100 ml buffer
I (10 mM Tris–HCl, pH 7.8, 200 mM KCl). The cell suspension
was added to 100 ml of buffer II (10 mM Tris–HCl, pH 7.8,
600 mM KCl, 2 mM EDTA, 40% (v/v) glycerol, 0.2% (v/v)
Nonidet P-40, 2 mM dithiotreitol, 0.5 mM phenylmethylsulpho-
nyl fluoride and protease inhibitor cocktail (Sigma)). The mixture
was shaken at 4uC for 40 min to promote cell lysis. The crude
lysate was then centrifuged at 16,0006g for 10 min to remove
cellular debris and DNA. Protein concentrations were determined
using the BCA Protein Assay (Thermo Scientific). After the
addition of 2-fold concentrated loading buffer, the samples (each
with 30 mg total protein) were incubated at 95uC for 1 min and
resolved by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis. Proteins were transferred onto nitrocellulose membranes
(Schleicher & Schuell), incubated with blocking solution contain-
ing 3% powdered milk. Immunodetection of HA-tagged I-SceI
was performed using anti-HA (MMS-101P Covance) mouse
monoclonal IgG1 diluted 1:200 in blocking solution, with an
incubation at 4uC overnight. Anti-b-actin (AC-15, 1:500; Sigma)
was used as a loading control. Bands were detected with a
fluorescent western detection (ECF) system (Amersham) and
visualized by using the LAS 4000 Imaging Quantum Dots
(Fujifilm).
Plasmids and hESC viral infection
The reporter plasmid pHPRT-DRGFP and the I-SceI expres-
sion vector pCBASce were described previously [22]. The
lentiviral backbone HFUW was obtained from the Trono
laboratory. The I-SceI cDNA was cloned into the lentiviral
backbone HFUW (courtesy of Eric Brown, University of
Pennsylvania) using an EcoRI-EcoRI fragment to create the
pHFUW-ISceI plasmid. The expression plasmid of zinc finger
nucleases targeting AAVS1 and the AAVS1-GFP donor plasmid
pGFP-AAVS1 were previously described [27]. The new donor
plasmid p84-DRGFP was generated from pGFP-AAVS1 by
isolating the 9.6 kb Sac1-Kpn1 fragment of pHPRT-DRGFP
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AAVS1 in place of the GFP gene and the SacI-Kpn1 DR-GFP
fragment was cloned into the resulting plasmid after Mlu1/Kpn1
digestion.
The lentivirus were produced by transient transfection of 293T
cells with pHFUW-ISceI and three package plasmids (pRSV-Rev,
pRRE and pVSVG) using lipofecatmine 2000 (Invitrogen). After
two days, supernatant was collected and used to transduce to
2610
5 cells in a single well of a 6-well plate along with 4 mg/ml
Polybrene (Sigma-Aldrich) for 18 hours.
DRGFP Reporter integration and AAVS1 gene targeting
For non-targeted integration, non-stem cell lines were trans-
fected with circular DRGFP plasmid (4 mg) was transfected into
10
6 non-stem cells by lipofectamine 2000 reagent (Invitrogen) in 1
well of a 6-well plate. After 24 hours, 1000 cells were split into a
10 cm dish with medium containing 1.5 mg/ml. For hESCs, the
cells were treated with 10 mM rho kinase (ROCK) inhibitor
(Calbiochem; Y-27632) 24 hours before the transfection. The
transfection was conducted by Amaxa nucleofection (Nucleofector
II, Lonza) using 2 mg of DRGFP plasmid and 2610
6 hESCs in
100 ml human stem cell nucleofector 2 solution with program A-
023, according to the manufacturer’s instructions. Cells were
subsequently plated on Matrigel-coated plate in mTeSR1 medium
supplemented with ROCK inhibitor for the first 24 h. Cells were
selected in puromycin 0.5 mg/ml beginning 48 hours after
nucleofection. Targeting was confirmed by PCR using the primers
in Table 1.
For gene targeting to p84 in non-stem cells, 6 mg of pZFN-
AAVS1 and 20 mg of circular p84-DRGFP were co-transfected
into 5610
6 non-stem cells by lipofectamine 2000 in a 10 cm dish.
The following steps are the same as non-targeted cells. For hESCs,
1 mg of pZFN-AAVS1 and 5 mg of p84-pDRGFP were nucleo-
fected into 2610
6 cells, as described above. To test the efficiency of
gene targeting by NHEJ, pHPRT-DRGFP was first linearized by
Sca1 and Kpn1 digestion. 5610
6 non-stem cells in a 10 cm dish
were transfected with 6 mg pZFN-AAVS1 using Lipofectamine
2000. The next day, the cells were transfected with 20 mgo f
linearized DRGFP by electroporation (Gene Pulser Xcell System,
Bio-Rad; 293 cell program, 0.4-cm cuvettes). Targeting was
confirmed by PCR using the primers in Table 1.
DNA repair and site-loss assay
Four days after I-SceI transduction, the percentage of GFP
positive cells was quantified by flow cytometry on a FACSCanto II
(BD BioSciences), as previously described [22]. Genomic DNA
was extracted with the Puregene Core Kit A (Qiagen) and the site-
loss assay and enzyme digestions were performed as previously
described [22,31]. Band intensities were quantified using ImageJ
software (http://rsbweb.nih.gov/ij/). To amplify individual im-
precise NHEJ events, the site-loss PCR product was digested with
I-SceI and LweI and individual resistant clones were sequenced
after TA cloning (Invitrogen). For each cell line, transductions,
flow cytometry and site-loss were performed at least twice and
averaged over three or more data points.
Quantitative PCR for DRGFP copy number
Primer sequences are listed in Table 1. Quantitative PCR was
performed using the CFX96 system (Bio-Rad). Samples (25 ml
each) were prepared in triplicate in a 96-well reaction plate. Each
reaction contained 20 ng genomic DNA, 200 nM of each primer,
12 ml water and 12.5 ml iQ SYBR Green Supermix (Bio-Rad) in a
2-step PCR: pre-heating at 95uC for 3 min and 39 cycles of
amplification and quantification (10 s at 95uC and 30 s at 60uC).
The reaction was monitored by melting temperature (10 s at 95uC
and 5 s at 65uC) to ensure a single PCR product. For clones with
random integration, primers amplifying the APE1 gene on chr.14
(Table 1) were used as reference. For AAVS1-targeting, a
sequence close to the integration site on Chr. 19 was used as
reference. All primer pairs were confirmed to have linear
amplification in the test range. The cycle threshold (Ct) of sample
was normalized with the reference gene Ct. The DRGFP insert
copy number was calculated according to the 2
DD Ct method [49],
using control cell lines known to have a single integrated copy as
reference [7,11,32,47].
The sequence surrounding the I-SceI site is present in both the
SceGFP and iGFP fragments of DR-GFP. Thus, we used a nested
PCR strategy to first amplify only the intact SceGFP fragments.
DNA was isolated 24 hours after I-SceI transduction and
subjected to conventional site-loss PCR for 18 cycles. 1 ml of the
product was utilized for qPCR, as described above. A reference
PCR amplified a similar length sequence downstream of iGFP.
Immunofluorescence imaging
Cells were fixed at room temperature with 4% paraformalde-
hyde for 30 minutes, washed with PBS, and then permeabilized
with 0.2% Triton X-100 for 30 min. The cells were treated with
blocking buffer (3% BSA + 5% FBS in PBS) for 2 h at room
temperature and then incubated with primary antibodies and
blocking buffer at 4uC overnight. Secondary antibody (1:1000) was
applied for 60 minutes after washing with PBS. The cell nuclei
were then counterstained with DAPI (1 mg/ml). The cells were
mounted with ProLong Gold antifade reagent (Invitrogen) and
then visualized and captured using a Zeiss Axio Observer.A1
fluorescence microscope. Foci were quantified by manual counting
after sample blinding.
The primary antibodies included mouse monoclonal antibodies
against human nestin and rabbit polyclonal antibodies against
GFAP (1:200 and 1:1000 both from Millipore MAB5326, AB804),
rabbit polyclonal antibodies against human Nanog and rabbit
polyclonal antibodies against human Oct3/4, rabbit polyclonal
antibodies against human PAX6 (1:100 from The Developmental
Studies Hybridoma Bank, University of Iowa), goat polyclonal
antibodies against human Sox1 (1:100 from R&D System). For
IR-induced damage foci, antibodies included mouse monoclonal
antibodies against human phospho-histone H2A.X (Ser139) (1:250
Millipore 05-636), rabbit polyclonal antibodies against human
Rad51(1:50 Calbiochem; PC130). Secondary antibodies used were
donkey anti-rabbit IgG andgoat anti-mouse or anti-rabbit IgG
with Alexa 488 or 555 (all from Invitrogen).
Supporting Information
Table S1 A comparison of imprecise NHEJ events from
H9 hESCs and U2OS cells harboring DR-GFP. Individual
products were isolated from cells after transduction with I-SceI.
Inserted nucleotides are in blue. Microhomology is underlined.
Some sequences were obtained more than once (see annotation at
the right of each row). I-SceI cleavage results in a 4 bp 39
overhang.
(DOC)
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